Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial

被引:20
|
作者
Wamalwa, Dalton C. [1 ]
Farquhar, Carey [2 ,3 ]
Obimbo, Elizabeth M. [1 ]
Selig, Sara [4 ]
Mbori-Ngacha, Dorothy A. [1 ]
Richardson, Barbra A. [5 ]
Overbaugh, Julie [6 ]
Egondi, Thaddeus [1 ]
Inwani, Irene [7 ]
John-Stewart, Grace [2 ,3 ]
机构
[1] Univ Nairobi, Dept Paediat, Nairobi, Kenya
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA USA
[4] Univ Colorado, Sch Med, Denver, CO USA
[5] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[6] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[7] Kenyatta Natl Hosp, Nairobi, Kenya
关键词
INFECTED CHILDREN; SELF-REPORT; ADHERENCE; STRATEGIES; EFFICACY;
D O I
10.1186/1758-2652-12-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: As highly active antiretroviral therapy (HAART) becomes increasingly available to African children, it is important to evaluate simple and feasible methods of improving adherence in order to maximize benefits of therapy. Methods: HIV-1-infected children initiating World Health Organization non-nucleoside reverse transcriptase-inhibitor-containing first-line HAART regimens were randomized to use medication diaries plus counselling, or counselling only (the control arm of the study). The diaries were completed daily by caregivers of children randomized to the diary and counselling arm for nine months. HIV-1 RNA, CD4+ T cell count, and z-scores for weight-for-age, height-for-age and weight-for-height were measured at a baseline and every three to six months. Self-reported adherence was assessed by questionnaires for nine months. Results: Ninety HIV-1-infected children initiated HAART, and were followed for a median of 15 months (interquartile range: 2-21). Mean CD4 percentage was 17.2% in the diary arm versus 16.3% in the control arm at six months (p = 0.92), and 17.6% versus 18.9% at 15 months (p = 0.36). Virologic response with HIV-1 RNA of <100 copies/ml at nine months was similar between the two arms (50% for the diary arm and 36% for the control, p = 0.83). The weight-for-age, height-for-age and weight-for-height at three, nine and 15 months after HAART initiation were similar between arms. A trend towards lower self-reported adherence was observed in the diary versus the control arm (85% versus 92%, p = 0.08). Conclusion: Medication diaries did not improve clinical and virologic response to HAART over a 15-month period. Children had good adherence and clinical response without additional interventions. This suggests that paediatric HAART with conventional counselling can be a successful approach. Further studies on targeted approaches for non-adherent children will be important.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The use of illustrated medication diaries to improve outcomes for children initiated on highly active antiretroviral therapy
    Kannigan, Yashodhara
    Spicer, Kevin B.
    Naby, Fathima
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2018, 19 (01)
  • [2] Home visits to improve adherence to highly active antiretroviral therapy: A randomized controlled trial
    Williams, Ann B.
    Fennie, Kristopher P.
    Bova, Carol A.
    Burgess, Jane D.
    Danvers, Karina A.
    Dieckhaus, Kevin D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (03) : 314 - 321
  • [3] Telephone support to improve antiretroviral medication adherence - A multisite, randomized controlled trial
    Reynolds, Nancy R.
    Testa, Marcia A.
    Su, Max
    Chesney, Margaret A.
    Neidig, Judith L.
    Frank, Ian
    Smith, Scott
    Ickovics, Jeannette
    Robbins, Gregory K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) : 62 - 68
  • [4] The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication
    Rash, Joshua A.
    Lavoie, Kim L.
    Sigal, Ronald J.
    Campbell, David J. T.
    Manns, Braden J.
    Tonelli, Marcello
    Campbell, Tavis S.
    CONTEMPORARY CLINICAL TRIALS, 2016, 49 : 47 - 56
  • [5] Using Client Feedback to Improve Couple Therapy Outcomes: A Randomized Clinical Trial in a Naturalistic Setting
    Anker, Morten G.
    Duncan, Barry L.
    Sparks, Jacqueline A.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2009, 77 (04) : 693 - 704
  • [6] Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy
    Ochieng, Washingtone
    Kitawi, Rose C.
    Nzomo, Timothy J.
    Mwatelah, Ruth S.
    Kimulwo, Maureen J.
    Ochieng, Dorothy J.
    Kinyua, Joyceline
    Lagat, Nancy
    Onyango, Kevin O.
    Lwembe, Raphael M.
    Mwamburi, Mkaya
    Ogutu, Bernhards R.
    Oloo, Florence A.
    Aman, Rashid
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (02) : E49 - E56
  • [7] Outcome of highly active antiretroviral therapy in HIV- infected Indian children
    Mukherjee, Aparna
    Shah, Nipam
    Singh, Ravinder
    Vajpayee, Madhu
    Kabra, Sushil K.
    Lodha, Rakesh
    BMC INFECTIOUS DISEASES, 2014, 14
  • [8] Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence
    Press, N
    Tyndall, MW
    Wood, E
    Hogg, RS
    Montaner, JSG
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 : S112 - S117
  • [9] Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country
    Kilaru, KR
    Kumar, A
    Sippy, N
    Carter, AO
    Roach, TC
    HIV MEDICINE, 2006, 7 (02) : 99 - 104
  • [10] Immunologic Effect of Zinc Supplementation in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lodha, Rakesh
    Shah, Nipam
    Mohari, Nivedita
    Mukherjee, Aparna
    Vajpayee, Madhu
    Singh, Ravinder
    Singla, Mohit
    Saini, Savita
    Bhatnagar, Shinjini
    Kabra, Sushil Kumar
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 (04) : 386 - 392